Rongsheng's products embody the Shanghai spirit of "embracing all rivers, pursuing excellence" and the Shanghai style quality of "planting in Shanghai and abiding by ingenuity".
Rongsheng biology regards innovation as life and strictly controls quality
The company is a high-tech enterprise engaged in the R & D, production and sales of vaccines and in vitro diagnostic reagents. Its products are mainly used for the prevention and diagnosis of infectious diseases.
1 varicella vaccine No. +57 in vitro diagnostic reagent No
8 vaccine projects under development +13 in vitro diagnostic reagent products under development
Cell factory culture technology
Large scale cell culture technology
Large scale virus purification technology
Vaccine preparation technology
Enzyme linked immunosorbent assay
Automation technology of agglutination test
Dry fluorescent technology
2021年12月获批国家药品监督管理局药品审评中心(CDE)“冻干人用狂犬病疫苗(Vero细胞)”“药物临床试验批准通知书”,目前正在启动临床工作。
2020年11月,荣盛生物“投资闵行月月签”启动高端创新疫苗研发及规模化生产基础设施改扩建。
药监综药管〔2019〕103号
国药监法〔2019〕32号